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The investigations of Westphal and his associates on the isolated moiety of 
bacterial endotoxin that they designated lipoid A  (lipid A) have attracted much 
interest. These workers emphasized that for lipid A to exert endotoxic effects it 
must be suitably dispersed in aqueous menstruum,  and they speculated that, 
were it possible to disperse lipid A in water in a manner comparable to its origi- 
nal state as bound to the polysaccharide cartier, it would then display biological 
activity similar to that of the intact endotoxin. Experimentally, they found that 
lipid A, dispersed by detergents or in low molecular weight dextrans, or coupled 
to an inert soluble protein, exerted at most one-fifth the potency of the endo- 
toxin itself (1-4). 
However, comparisons of the potency of dispersed lipid A with that of the 
very endotoxin from which the lipid was derived are not readily identifiable in 
existing  reports. In view of our findings  (5, 6), in which correlations of potency 
with lipid content were not evident, and the continuing scarcity of relevant bio- 
logic data,  we considered it necessary to obtain,  by well established dose-re- 
sponse assays, such comparative data. These assays showed that lipids isolated 
from endotoxins of high initial potency exerted an insignificantly  small fraction 
of the potency of the parent endotoxins. 
When the polysaccharide moiety is liberated by acid hydrolysis (e.g., during 
the preparation of lipid A), it no longer possesses any endotoxic potency. Com- 
parison of such a totaUy inactive fraction with active lipids does, of course, high- 
light the apparently greater importance of the lipid part. But we also found that 
lipid obtained by a non-hydrolytic procedure, which did not destroy the activity 
of the remainder of the endotoxin complex,  was as active as lipid A. This sug- 
gested that the activity of these lipids is separate from, and of a different order 
from, the activity of the principal toxic moiety of bacterial lipopolysaccharides. 
The activity of lipids is obviously resistant to acids,  but the major activity of 
endotoxins is not. 
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Hydrolysis of endotoxin with acid did, in another way, elucidate the function 
of lipid in endotoxin. When samples were taken for bio-assay at brief intervals 
following initiation of the hydrolytic process,  potency was seen to be rapidly 
and progressively reduced before measurable amounts of lipid were released. 
This experiment provided an alternative explanation for the activity, interme- 
diate between that of lipids and that of endotoxins, of so called "artificial lipo- 
proteins" produced by Umkupplung (1, 3). 
Materials and Methods 
A. Chemical Analysis.--The methods used for chemical analysis of the bacterial fractions 
are described in an accompanying paper (6).  Since other investigators (7)  have used more 
vigorous conditions of hydrolysis than we have for determination of hexosamine in lipoid ma- 
terial, parallel determinations of hexosamine on a representative sample of lipid A were made 
to compare the effects of different conditions of hydrolysis. Values obtained after 6 hours of 
hydrolysis with 3 N hydrochloric acid were not significantly different from those found when 
hydrolysis with 6 N hydrochloric acid was prolonged for 12 hours at 100°C. 
B. Preparation of Endotoxins and Lipids.--Unless otherwise stated, endotoxins  and "hydro- 
lytic" lipid A and lipid W were prepared as described under Materials and Methods in an 
accompanying paper (6).  The methods for non-hydrolytic dissociation of bound lipid from 
endotoxin are described under Results in the same report. The fraction referred to as non- 
hydrolytic lipid I  represents the chloroform-soluble extractives recovered by evaporation of 
the filtered chloroform-methanol reaction mixture. The fractions designated non-hydrolytic 
lipid II a and IIb were derived from the extractives recovered by evaporation of the filtered 
monochlorobenzene-ethanol reaction mixture; lipid II a  was the chloroform-soluble portion 
and lipid IIb the water-soluble remainder of the residue after evaporation. Preparations from 
other sources are acknowledged in the text. 
C. Endotoxin  Bio-Assays.-- 
1. General considerations: In addition to the specific requirements for the individual assays, 
as detailed below, the following were considered to be basic prerequisites for the quantitation 
of endotoxin. Animals employed for each of the assays were uniform as regards strain, source, 
and weight. The size of the experimental groups varied in accordance with the requirements of 
each assay, i.e.,  the number considered to provide statistically reliable data. These groups 
ranged in size from as many as 32 (for measurement of resistance to infection) to as few as 2 
(for determination of febrile response). Reference endotoxins were included in each test to 
ascertain the responsiveness  of each set of animals. The primary objective in these assays was 
to administer to groups of animals amounts of the test materials which would evoke the par- 
ticular response in 15 to 85 per cent of the animals, i.e., bracket the median dose. 
2. Lethality for mice: Assays were performed with 21-day-old male white mice of the Rocky 
Mountain Laboratory (RML) strain weighing 10 to 12 gin. Graded doses of endotoxin were 
injected intraperitoneally into groups of 5 mice each. Mice were observed for 6 days and any 
dying more than 72 hours after injection were examined in the gross and by culture for evidence 
of extraneous cause of death. Median lethal doses (LDs0) were calculated by the method of 
K~irber (8). Analysis of the variation to be expected in this method has been reported earlier 
(9). 
3.  Tumor damage:  Hemorrhagic necrosis was determined with a  modification  (10) of a 
previously described method (11). Sarcoma 37 was implanted as a tumor mash into the thigh 
muscle of 2- to 3-month-old CAF~ mice. 6 days later mice bearing such implants were randomly 
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of endotoxin.  Each set of bio-assays included two control groups:  the first consisted of  10 
untreated mice, to disclose the extent of spontaneous hemorrhage or necrosis in the tumors 
of the set; the second consisted of 10 mice which had been given 10  ~g of Serratic~ marcescens 
endotoxin to ascertain the responsiveness of the set of  tumors  to  endotoxin.  The animals 
were autopsied the following day. Tumors were cut open and examined in the gross for in- 
duced hemorrhage. Values for TDs0 were read from the slope of dose-response obtained by 
plotting the percentage of mice with induced tumor damage against log dose of endotoxin. 
4.  Resistance  to challenge witk Salmonella  typkosa:  The test was adapted from procedures 
commonly employed for assay  of  typhoid  vaccine.  Since materials antigenically unrelated 
to  S.  typhosa  were  as protective  as  any homologous preparations,  the  effect  measured is 
termed "non-specific resistance." Male white mice, 4  to 5 weeks old, housed 2 per jar, were 
assigned to treatments in groups of 32 mice per dose level by statistical randomization. Graded 
doses of preparations in physiological saline or in saline containing 0.5  per cent tween 80 
were injected intravenously, and 24 hours later the mice were challenged intraperitoneally 
with 80 (range 50 to 110)  million S. typhosa  (3.6,  range 2 to 6, LDs0)  grown 6 hours on agar 
and injected without mucin.  Survivors were counted  72  hours after challenge, an interval 
sufficient to include all deaths attributable to S. typkosa.  Values for EDs0 were read from the 
slope of dose-response obtained by plotting percentage (transformed to probit) of surviving 
mice against log dose of material under test. Equivalent groups of control mice were prepared 
with injections of diluent.  Ordinarily about 90 per cent of  these succumbed,  but extreme 
effects ranged from as low as 75 per cent to 100 per cent. 
5.  Primary  inflammation  of rabb#  skin:  These  assays were  conducted  as  described  by 
Larson et al.  (9).  Graded doses of materials under test were injected intracutaneously (0.2 
ml volume)  in bands on the lateral surfaces of at  least 4  rabbits each.  Primary reactions 
present 48 hours after injection, consisting of  edema and/or  erythema extending at  least 
5 X  5 mm, were recorded and used for calculation of average threshold dose or SLDs0 (equiva- 
lent to median effective dose except for method of estimating standard errors). 
6.  Pyrogen  response:  Data supporting the validity of the procedure have been reported 
(12). The following summarizes the requirements and the distinctive features of the method. 
Variability in the pyrogenic response of individual rabbits could be kept to a  minimum by 
observing certain precautions such as: adequate training (in stocks) of the animals to handling 
and restraint; application of minimal restraint during the test; use of animals from a  single 
source of supply,  weighing 2 to 2.5 kg and having a  base line temperature of 38.5-39.9°C. 
For the recording of temperatures, rectal thermocouples, connected to an automatic multi- 
point recorder (Minneapolis-Honeywell Regulator Co., Minneapolis) were inserted to a  depth 
of 4 inches or more. Temperatures were measured immediately before injection of  endotoxin 
and at 12 minute intervals thereafter until they had returned to normal. The febrile responses 
were plotted on 1 X  1 standard graph paper with I°C and 1 hour equalling 1 inch. The area 
under the curve was measured in square centimeters with a  compensating polar planimeter. 
The fever index (FI)  thus obtained represents a  measure of the height and duration of  the 
febrile response. Groups of rabbits were given graded doses of the endotoxin under test so as 
to obtain data for calculating the dose required to produce a  fever index of 40 cm  * (FI~), a 
value which was shown to fall on the linear portion of the dose-response curve (12). 
RESULTS 
Biologic Potencies of Endotoxin (Aqueous Ether Extract) versus Lipid A.--Such 
biological activity as is possessed by lipoid fractions of endotoxins is most evi- 
dent when the preparations are well dispersed. By shaking chloroform solutions 
of the lipoid materials with hot solution of tween 80 in saline, and distilling off 668  ENDOTOXINS AND LIPOID FRACTIONS 
the chloroform in a 70°C water bath, it was possible to obtain stable emulsions 
or only slightly turbid colloidal solutions. Lipoid fractions thus dispersed were 
compared in parallel  dose-response assays with  the  parent endotoxins in  the 
same diluent.  Specimen data from several such comparisons are presented in 
Table I. All of the original endotoxins were dialyzed 68 per cent ethanol-precipi- 
tated aqueous ether extracts of Salmonella enteritidis,  of comparable lethality 
TABLE I 
Endotoxins and Homologous Preparations of Lipid A  Compared with Regard to  Pyrogenicity 
for Rabbits, Tumor-Damaging Potency, Stimulation of Non-Specif~ Resistance to 
Infeaion,  and Lethality for Mice 
Preparations 
Se 157/161 
Endotoxin. 
Lipid A. 
P 1032-1038 
Endotoxin. 
Lipid A. 
~e 162/168 
Endotoxin. 
Lipid A. 
3e 143/148 
Endotoxin, 
Lipid A. 
5e 206/208 
Endotoxin. 
Lipid A. 
Pyrogenicity 
FI,o 
#g 
0.18 
>250 
0.04 
8.8 
0.39 
>300 
0.06 
66 
0.065 
~210 
Tumor damage 
TD6o 
#g 
0.13 
550 
0.2 
>100 
0.25 
>100 
0.21 
~390 
Protection 
EDbo 
t~g 
0.24 
~50 
0.25 
>50 
0.20 
>50 
L 
Lethality 
LDio 
~g 
270 
310 
530 
270 
220 
for mice, prepared over a period of several months from freshly harvested cells. 
Lipoid fractions were obtained from these in the manner described earlier for 
preparation of "lipid A" (6). 
For reasons elaborated by Keene et al. (12), the FI40 is considered to provide a 
more accurate measure of febrile responses in rabbits than the minimum pyro- 
genic dose (MPD), which has also been determined for several preparations (see 
Table II). In all comparisons, the FI40's of lipid preparations were greater than 
those of the corresponding endotoxins by a factor of several 100-fold, or more. 
Variation in  the  pyrogenicity of the  original endotoxins was less  pronounced 
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In assays for capacity to induce hemorrhagic necrosis in Sarcoma 37 implants 
in mice, original endotoxins were uniformly effective in small doses (TD~0's,  < 
0.3/zg); end points were not reached with lipid A unless doses considerably in 
excess of 100 #g were employed. 
Non-specific stimulation of resistance to infection is now regarded as an estab- 
lished property o~ endotoxins. Lipid A has also been shown to be active in this 
respect  (4), but quantitative  measurements are rendered difficult, not only by 
TABLE II 
Pyrogenicity,  Induction  of  Tumor  Damage, and  Stimulation  of Non-Specific  Resistance  in 
Mice by Lipids and by Parent Endotoxins from Salmonella enteritidis 
Preparations 
Aqueous ether extract 
Endotoxin .................... 
Lipid W ...................... 
Lipid A ...................... 
Phenol-water extract 
Endotoxin .................... 
Lipid W ...................... 
Lipid  A ...................... 
TCA extract 
Endotoxin .................... 
Lipid  W .................... 
Lipid A ..................... 
MPD* 
~g 
0.0005 
3.1 
0.64 
0.0003 
2.6 
m 
Pyrogenicity 
Fho 
0.18 
> 250 
>250 
0.14 
115 
39 
0.13 
32 
30 
Tumor damage 
TD6o 
0.13 
>1000 
550 
0.3 
55O 
0.3 
3OO 
Protection 
ED~o 
0.24 
>50 
~50 
<0.1 
26 
13 
<0. I 
50 
7 
* MPD (minimum pyrogenic dose) =  #g of product per rabbit required  to elevate tem- 
perature  0.6°C. 
the usual variability in mouse protection tests and quantal response data in gen- 
eral, but also by the fact that the period of maximum resistance is dependent on 
factors peculiar to individual  preparations  and on the amount of material  in- 
jected (13). Furthermore, we have found a good deal of seasonal variation in the 
capacity of mice to respond in this manner. Nevertheless, a test modeled on one 
employed for assay of typhoid prophylactics, with appropriate selection of dose, 
route,  and  interval  between  injection  and  challenge  of animals,  yielded  data 
which  could be  interpreted  numerically  and used  for comparisons.  Complete 
endotoxius  almost  invariably  gave  linear  responses  to  dose  in  this  test.  Re- 
sponses to lipid fractions showed much greater variability in repeated tests. In 
most instances,  amounts  of such preparations  sufficient  to bracket  the 50 per 670  ENDOTOXINS  AND  LIPOID  FRACTION'S 
cent response level were not available. In all comparisons, the endotoxins were 
more effective by margins ranging from at least 100- to several 1000-fold. 
One of the most reproducible measures of toxicity, lethality for mice, could 
not be employed for comparison of lipids and parent endotoxins because the 
lipid preparations did not kill mice. In limited trials with rabbits, a more suscep- 
tible species,  intravenous injection of lipid A in amounts ranging from 500 to 
10,000/zg  (trichloroacetic acid (TCA) extract) (Table II) did not produce shock 
or death, whereas the original endotoxins employed were lethal in amounts of 2 
to 10 #g. 
Biologic Potencies of Endotoxins  Prepared from  S.  enteritidis  by  Various 
Methods versus Lipids Derived  from Them.--In another series of experiments we 
examined lipids A and W  derived from endotoxins extracted by different pro- 
cedures:  a  Boivin type TCA  extract,  a  purified phenol-water  extract  (after 
Westphal), and a typical aqueous ether extract. These materials were compared 
for pyrogenlcity, induction of tumor damage, and stimulation of non-specific 
resistance (Table II). The aqueous ether endotoxin yielded a lipid W which was 
devoid of hexosamine (< 1 per cent). Lipid A prepared from the same material 
had 7.3 per cent hexosamine, which is considerably less than the 18 to 20 per 
cent reported for lipid A derived from Escherichia coli and Salmonella abortus 
equi (1, 7, 14). Both lipids were found to contain about 1 per cent hexose by the 
anthrone method. Pyrogenic activity, first measured in terms of the MPD, was 
in the range reported by Westphal for lipid A dispersed in tween (1, 4); values 
of 0.64 and 3.1 #g for lipids A and W, respectively, were obtained. Although ini- 
tially impressive, these values represent less than 1/1000 of the activity of the 
parent endotoxin (MPD  =  0.0005 #g). 
The phenol extract, yielded lipid W  containing 2.5 per cent hexosamine and 
lipid A with 5.6 per cent hexosamine. Hexose contents were 1.4 and 1.8 per cent, 
respectively. The MPD of this lipid A was about 10,000 times that of the endo- 
toxin. Subsequent comparisons, based on determinations of fever index, revealed 
that FIJs for all lipid fractions, including those prepared from the TCA ex- 
tract,  were at least several  100-fold  greater than those of the corresponding 
endotoxins. In tumor damage assays, none of the lipids displayed more than 
1/1000 of the activity of the endotoxins. Median effective doses for protecting 
mice against challenge with S. typhosa showed differences in the same direction. 
In general, the data in Table II indicate that lipids separated from endotoxins 
by two different conditions of hydrolysis have roughly the same low order of ac- 
tivity in the host reactions studied. Additionally, results of these tests on lipid 
fractions and parent endotoxins extracted by three standard procedures agree 
well with results in Table I, where attention is restricted to aqueous ether ex- 
tracts. 
Thus far only tests with the chloroform-soluble lipids present  in acid hy- 
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approximately one-half of the lipoid substance in aqueous  ether- or phenol- 
extracted toxins, determined as fatty acid ester (FAE), was found in the water- 
soluble fraction which also contained the polysaccharide haptene. Such fractions 
were tested in doses adjusted to contain FAE equivalent to that of the chloro- 
form-soluble lipids with which they were compared. No measurable activity was 
observed. Another portion of the FAE in aqueous ether (but not in phenol) ex- 
tracts, along with a major portion of amide-bound fatty acids (FAA) appeared 
in a water- and chloroform-insoluble fraction (6). One sample of such a fraction 
gave the following analysis: 6.7 per cent N, 30.5  per cent FAE, 6.2 per cent 
FAA, 10.8 per cent hexosamine, 2.2 per cent hexose. For testing, it was evenly 
dispersed in tween-saline with the aid of ultrasonic vibration. This fraction also 
was without measurable activity in tests for pyrogenicity and non-specific pro- 
tection. It therefore appears that the active lipoid materials in an acid hydroly- 
sate of endotoxin reside in the chloroform-soluble portion. 
Tests with Lipid A Prepared from E. coli.--A specimen of lipid A from E. coli, 
prepared  at  the  Merck  Institute  for Therapeutic  Research,  Rahway,  New 
Jersey was furnished by Dr. H. J.  Robinson. Other samples of "crude" and 
"purified" lipid A were prepared from the same organism by a modified proce- 
dure recently described by Nowotny (15) and others (14). It has been reported 
that lipid purified in this manner is a  derivative of D-glucosamine  phosphate 
(4,  16)  containing about 20 per cent hexosamine (14).  Since endotoxins from 
which these lipids has been obtained were not available, an aqueous ether ex- 
tract from S. enteritidis and lipid A derived from it (Se 157/161,  Table I) were 
included as reference materials for the protection test. The protection data in 
Table III were obtained in two separate tests. Characteristically, results with 
the  endotoxin were uniform and similar to  those obtained earlier  (Table  I). 
The lipids which were retested, however, gave disparate results in the two tests, 
although the range of doses employed in the second test was better suited to 
the  potency of the materials.  The findings in  test  I  support  the  conclusion 
that lipid A prepared from an aqueous ether extract of S. enteritidis was not 
less potent than the lipid A from a phenol-water extract of E. coli. In neither 
test was there any significant difference in potency between the "crude" and 
"purified" preparations of lipid A. 
The lipids from E. coli were also tested for pyrogenicity and tumor-damaging 
potency. In these tests they exhibited a range of values similar to that observed 
for RML preparations (Table I). 
Biologic Properties of Lipids Obtained  from Endotoxins by Non-Hydrolytic Pro- 
cedures.--An additional experiment was designed to compare the properties of 
parent  endotoxin, lipoid materials prepared  by non-hydrolytic methods  (see 
Materials and Methods), and the residual endotoxin. 
The data in Table IV show that the original and final endotoxins did not differ 
in their capacity to stimulate non-specific resistance of mice to infection with S. 672  ENDOTOXINS  AND  LIP01D FRACTIONS 
typhosa, to induce primary inflammation of rabbit skin, and to produce fever in 
rabbits. The LDs0's for mice of original and final endotoxin were 0.53 mg and 
0.71 mg, respectively. Of the lipoid fractions, the chloroform- and water-soluble 
portions of the monochlorobenzene-ethanol extract  (non-hydrolytic lipids II a 
and II b) had discernible activity. As has often been observed in tests of "hydro- 
lytic" lipids, the non-hydrolytic lipids likewise gave erratic responses to graded 
doses in the protection test. Although mice receiving these products fared better 
TABLE  III 
"Crude"  and "Purified"  Samples of Lipid A from Escherichia coil Compared with Endotoxin 
and Lipid A from Salmonella enteritidis with Respect to Pyrogenicity,  Tumor Damage, 
and Stimulation  of Non-Specific Resistance 
Preparations 
Phenol-water extract of E.  coli-- 
0111 
"Crude" lipid A*.. 
"Purified" lipid A* 
E. coli, "purified" lipid A~. 
&queous ether extract of S. enteri- 
tidis 
Endotoxin§.  ., 
Lipid A§. 
Protection 
ED~o 
Test 1  Test 2 
t*g  ug 
> 50  32 
>50  27 
--  ~60 
0.3  O.2 
~60 
Pyrogenicity 
FI,0 
tzg 
16 
58 
200 
o.18ll 
>25oi[ 
Tumor damage 
TD6o 
~g 
~-~60 
>100 
700 
o.13ti 
55otl 
* Prepared according to patent description of Dr. A. Wander, Forschungsinstitut,  Frei- 
burg  (Breisgau)-Z/ihringen (14). 
Prepared by Merck, Sharp and Dohme, Research Laboratories, Rahway, New Jersey, 
lot  No.  L670077-0-6. 
§ Control materials prepared at the Rocky Mountain Laboratory  (6). 
I[ Data  from  Table  I. 
than the controls, the range of doses tested did not attain protection of 50 per 
cent of the animals. Non-hydrolytic lipid II a was found consistently to possess 
activity of at least the same order of magnitude as that of lipid A. Its FAE con- 
tent (e.g., 26.4 per cent) was similar to that of preparations of lipid A from aque- 
ous ether extracts (6). Attention is directed to the high FAE content (e.g., 58.5 
per cent) of the water-soluble non-hydrolytic lipid IIb. The chloroform-meth- 
anol extracts (non-hydrolytic lipid I) which also were rich in FAE (e.g., 51.2 per 
cent) displayed no measurable activity in the bio-assays, although at high dose 
levels they occasionally produced atypical dermal lesions in rabbits. In four dif- 
ferent non-hydrolytic lipid fractions examined  (including  those in Table IV), IIASKINS,  LANDY~  MILNER,  AND  RIBI  673 
the content of hexosamine was low (1.5 to 3.3 per cent) as was that of hexose 
(0.9 to 1.2 per cent, anthrone method). Thus, among lipids derived from endo- 
toxins by non-hydrolytic, as well as by hydrolytic, procedures, no correlation 
was evident between content of hexosamine, or of hexose, and biologic potency. 
Biologic Properties of Lipid-Casein Complexes.--Those who suggest that toxic 
and other host-reactive properties of endotoxins reside chiefly in the lipid moi- 
ety account for the feeble activity of isolated lipids by their hydrophobic nature 
(1, 3). This view is supported by the fact that activity is increased when lipoid 
fractions are redispersed in aqueous menstruum by detergents. Therefore, pro- 
viding a new hydrophilic carrier by Umkupplung (transference) of lipid from the 
TABLE IV 
Some Biological Properties of "Non-Hydrolytic Lipids" versus Parent Endotoxin 
(Aqueous Ether Extract  from Salmonella enteritidi~ 
Procedure  Preparation 
Endotoxin  ..........  Original 
ZHClwMeOH-extrscted-* CHCLt-soluble (non- 
;  hydrolytic lipid I) 
J  CHCh-soluble (non- 
hydrolytic lipid II a) 
:6H6Cl-ETOH-extracted --~Water-soluble  (non- 
hydrolytic lipid II b) 
Zndotoxln ......  Final 
Recovery 
per cent 
100 
3.9 
1.8 
1.6 
Protec-  Toxicity  Pyro- 
tion  genicity 
ED60  SLD60  Fh0 
~g  pg  ~g 
1.1  0.20  0.39 
>50*  ~125  >1000 
>50§  10.9  28 
>50§  --  160 
2.0  0.24  0.43 
Hexosa- 
mine 
~er cent 
2.2 
t.5 (0.9)~ 
2.4 (t.2)~ 
2.3 
* No evidence of protection by doses up  to 50/~g. 
:~ Per cent hexose as determined by the anthrone method. 
§ Significant protection, but less than 50 per cent survival with dose of 50/~g. 
original polysaccharide carrier to an inert protein such as casein would be ex- 
pected to permit the lipid to react in a nearly optimal degree of dispersion and 
thus increase its biological activity. Such artificial lipoproteins have been re- 
ported to be toxic and to have as much as one-fifth the pyrogenic activity of the 
original endotoxin (3). 
In the present work, the artificial lipoproteins were prepared  (1, 3) from a 
phenol-water extract of S. enteritidis,  isolated and purified by the method of 
Westphal eL al.  (17),  and from aqueous ether extracts whose nitrogen content 
had been reduced by ethanol-salt fractionation (18). A 0.3 per cent solution of 
endotoxin was mixed with an equal volume of a 0.055 per cent solution of casein 
and the pH adjusted to 8 by addition of 0.1 ~ sodium hydroxide. After the mix- 
ture had stood for 15 minutes, the pH was adjusted to 6 with 0.1 N hydrochloric 
acid. Glacial acetic acid was then added to make a concentration of 1 per cent 674  ENDOTOXINS AND LIPOID FRACTIONS 
(i.e., about one-sixth N) and the mixture was heated in a boiling water bath for 
1.5 hours and then neutralized. It is believed that, under the influence of alkali, 
endotoxin couples with casein; then, during acid hydrolysis, degraded polysac- 
charide is split off, leaving only lipid from the original endotoxin coupled to 
casein (1, 3). The complex is rendered soluble when the reaction mixture is neu- 
tralized. 
Pertinent data from biological tests of these neutralized solutions appear in 
Table V. The LDs0's for mice of the starting endotoxins were of the order of 250 
#g, whereas the homologous lipoproteins, compared on the basis of their original 
content of endotoxin, were not lethal for mice in doses as high as 4  mg. The 
TABLE V 
Biological Properties  of Endotoxins  from Salmonella  enteritidis  and Artificial  "Lipoproteins" 
Prepared from Them 
Aqueous ether 
Endotoxin  ................... 
"Lipocasein". ............... 
Aqueous ether 
Endotoxin  ................... 
"Lipocasein". ................ 
Phenol-water 
Endotoxin  ................... 
"Lipocasein"  ................. 
Nitrogen  Mouse  Rabbit  Pyrogenicity 
LDso  SLDso  MPD 
#er ce~t 
1.3 
1.6 
2.5 
t*g 
230 
> 1500 
270 
> 2000 
230 
>4000 
t*g 
0.4 
19 
0.39 
38 
1.2 
>200 
t~g 
O. 0002 
0.012 
0.00001 
0.018 
0.0003 
>0.1;  <1.0 
original  endotoxin produced typical raised  primary lesions  in  rabbit  skin  in 
amounts varying between 0.4 and 1.2 #g; however, the "lipocaseins" produced 
atypical dermal reactions in rabbit skin and consequently the values obtained 
are difficult to interpret. Nevertheless, lipoproteins had, at best, about 1~0 the 
activity of the original endotoxin. The regression of LDs0's (mice) on SLDs0's 
(rabbits) (9) indicates that the highest doses of "lipocasein" tested in mice did 
not approach the LD60. The final products, while appreciably pyrogenic for rab- 
bits (MPD, 0.01 to  >0.1/zg), had no more than ~6o the potency of the starting 
materials  (MPD,  0.00001  to 0.0003  #g).  This loss  of potency was  evidently 
brought about during the limited acid hydrolysis since, prior to that step, the 
endotoxin-casein mixture was found to possess full activity. Furthermore, the 
pyrogenic potency of "lipocaseins"  appeared to be greater than that of lipid A 
(see Table II). The question arose as to whether this might simply reflect the 
less vigorous hydrolysis to which the lipopolysaccharide-protein complexes were HASKINS~  LANDY~  M.ILNER,  AND  RIBI  675 
subjected. Accordingly, a  kinetic study of the hydrolysis of endotoxin was de- 
signed in order to determine the rate at which changes were effected in chemical 
composition and in biological activity. 
A  Kinetic Study of the Acid Hydrolysis of Endotoxin.-- 
The  product  employed  for  this  investigation was  an  aqueous  ether  extract  of 
S. enteritidis  which contained 2.8 per cent nitrogen and 6.4 per cent lipid A. Samples 
of 125 mg were placed in each of eight screw-capped tubes; each sample was dissolved " 
in 25 ml of distilled water and the tubes were heated in a boiling water bath. To each 
tube was added an equal volume (25 ml) of boiling 0.2 ~¢ acetic acid. The tubes were 
TABLE  VI 
Alteration of Endotoxin During  Acid  Hydrolysis: Stimulation  of Resistance to Infection 
Test No.* 
I 
II 
IlI 
II 
I 
III 
I 
II 
I 
III 
II 
Duration of 
treatment 
with acid 
m/n. 
0 
0 
0 
5 
15 
30 
45 
60 
90 
180 
360 
0.05 
6/32~ 
10/32 
15/32 
11/32 
11/32 
Surviving mice, dose per animal, j*g 
0.5  5.0 
13/30  29/32 
15/32  29/32 
20/32  29/32 
18/32  29/32 
15/32  19/32 
17/32  18/32 
7/32  16/32 
6/32  15/32 
4/32  11/32 
9/32  9/32 
8/32  5/32 
50 
21/32 
21/32 
25/32 
12/30 
16/32 
10/32 
ED6o 
~g 
0.45 
0.31 
0.10 
0.22 
0.54 
0.37 
6.8 
5.0 
>50 
>50 
>50 
* Considerations of time and numbers of animals involved made it necessary  to conduct 
these tests on 3 separate occasions. 
:~ Survivors/number of mice challenged with 80 million S. typhosa in saline. 
sealed, while in  the boiling water bath, and  were removed individually at intervals 
ranging from 5 to 360 minutes. A control (zero time sample) was prepared by dissolv- 
ing 125  mg of the same preparation in 25  ml of water at room temperature, adding 
25 ml of 0.2 ~¢ acetic acid, and immediately neutralizing the solution with 3 N NaOH. 
Upon removal from the bath the tubes were quickly cooled to room temperature and 
20  ml  samples (50 mg endotoxin)  were  withdrawn  for lipid determination; the  re- 
maining 30 ml, in each case, was neutralized with 3 ~ NaOH. The latter portions were 
reduced  in  volume  in  vacuo to  provide  appropriate  concentrations  for  bio-assays, 
and stored in the frozen state (-20°C)  until used. To determine the amount of lipid 
released at the various stages, hydrolysates were extracted 4 times with 5 ml portions 
of  purified  chloroform;  the  chloroform  solutions were  dried  with  Na2SO4,  filtered, 
evaporated  to  dryness in  tared  dishes,  and  weighed.  In  each  case,  the  remainder 676  ENDOTOXINS  AND  LIPOID  FRACTIONS 
(water  phase)  was  immediately neutralized with  3  N  NaOH;  a  2  ml  sample  was 
removed,  dialyzed  against  distilled  water,  and  lyophilized for  chemical  analysis. 
TABLE VII 
Alteration of Endoloxin During Acid Hydrolysis: Induction  of Tumor  Damage in  Mice 
Duration of 
treatment 
with acid 
mm. 
0 
5 
15 
30 
45 
60 
90 
180 
360 
Induction of hemorrhagic  necrosis in Sarcoma 37, dose per mouse, ug 
I  100 
i-- 
10/10 
10/10 
30 
1o/I 
7/I 
2/I 
0/5 
0/6 
0/6 
10 
ii/i 
9/1, 
3/11 
0/1~ 
0/5 
0/5 
0/5 
3 
6/6* 
6/6 
10/10 
S/lO 
O/lO 
O/lO 
O/5 
....  1  ]  0.3  0.1  I  0.03 
1/1111O/lO15/lO[O/lO 
9/10  /  7/1010/1010/10 
6/10  I  0/1010/101 
O/lO /  0/10i 
O/lO 
0/6 
Dose required 
to produce 
tumor damage 
in 50 per cent 
of the mice 
(TD6o) 
~zg 
0.1 
0.2 
0.8 
4.0 
18 
40 
>30 
>30 
>30 
* Number damaged tumors/Number mice tested. 
TABLE VIII 
Alteration of l~ndotoxin During Acid Hydrolysis: Lethality for Mice 
Duration  Lethality for mice, dose per animal, mg 
of treat- 
ment with 
acid 
m/n. 
0 
5 
15 
30 
45 
6O 
90 
180 
360 
0.125  ~5 
l/s* I  4IS 
Ol5  I  Ol5 
1/5 
05  1~ 
4/5  I  5/5 
4/5  ]  5/s 
1/5  I  2/s 
o/s  I  1/s 
0/5 
2.0 
5/5 
4/5 
0/5 
0/5 
3.0 
0/5 
4.0 
5/5 
3/5 
1/5 
0/5 
6.0 
1/5 
8.0 
015 
LD~0 
I0.0 
~g 
200 
410 
930 
1,400 
3,700 
>4,000 
>6,000 
>8,000 
0/5  >10,000 
* Deaths/No. of mice tested. 
In order to assess the biologic implications of the physicochemical changes wrought 
by acid hydrolysis, samples of the reaction mixtures for the various intervals were 
submitted to bio-assay. In seeking to determine which assay was most suitable for 
this purpose we were mindful of  the  fact that  endotoxins elicit a  diverse array of 
reactions in the mammalian host and that there is no general agreement as to which 
of these is the most reliable or objective measure of the potency of these complexes. TABLE  IX 
Alteration of Endotoxin During Acid Hydrolysis:  Capacity to Produce Inflammation 
in Rabbit Skin 
Dura- 
tion of 
treat- 
ment  I  No.  with 
acid 
rai~. 
0  1 
2 
3 
4 
5  1 
2 
3 
15  1 
2 
3 
4 
30  1 
2 
3 
4 
45  1 
2 
3 
4 
6O  1 
2 
3 
9O  1 
2 
3 
4 
180  1 
2 
3 
4 
360  1 
2 
3 
4 
Dermal reaction, dose per site injected,  ~g 
100  0.10  ,50  2,5  12.5  6.25  3.12  1.56 
[SLDsq  =  0.24~g] 
[SLDso =  0.58 #g] 
[SLDeo  =  0.58 ~g] 
[SLDso =  1.36 #g] 
[SLD5o  =  3.91 ~tg] 
[SLDso  =  7.31 #g] 
[SLDso =  6.25 #g] 
[SLDso  =  15.6 gg]  + 
+ 
+ 
+ 
[SLDeo  =  31.2/~g]  + 
+ 
+ 
+ 
+ 
+  i+ 
+ 
i 
0  0 
+  0 
+  + 
+  0 
+  0 
+  0 
+  + 
+  0 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
0 
+ 
0 
0 
0 
+ 
0 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
0 
+ 
0 
0 
+ 
0 
+ 
0 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+  + 
+  + 
+  0 
0  0 
+ 
+ 
0 
0 
0 
0 
0 
+ 
0 
0 
0 
0.78  0.39  0.20 
+  0  0 
+  +  0 
+  +  + 
+  +  0 
+  +  0 
+  0  0 
0  0  0 
+  0  0 
+  0  0 
+  +  0 
0  0  0 
0  0 
+  0 
0  0 
0  0 
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TABLE X 
Alteration of Endotoxin During Acid Hydrolysis: Pyrogenic Response 
Duration of 
treatment 
with acid 
45 
60 
90 
180 
360 
0.04 
o 
34  33 
3 
11  14 
16 
19 
15  23  217}  22 
30  23} 
24  24 
25 
Fever indices of individual rabbits,  dose per animal, t*g 
25.0  125.0 
51}  53 
55 
44  6 
19}  41}  41 
22  23  41 
28 
250.0 
54 
Dose required 
to produce  a 
fever index of 
40 cm~  (Fho) 
~g 
0.07 
0.26 
0.18 
0.38 
0.50 
0.75 
5.2 
21 
100 
Furthermore,  it was possible that changes produced in the endotoxin might be selec- 
tive  and  not  apply  equally  for  the  different  properties.  It  was  therefore  deemed 
essential  to  utilize  a  number  of  the  established  dose-related  bio-assays  based  on 
characteristic host reactions to endotoxin. 
Five standardized procedures were selected. They included assays for pyrogenicity, HASKINS,  LANDY,  MILNER,  AND  RIBI  679 
tumor damage, lethality, protection, and dermal inflammation. In addition to their 
obvious pertinence to the present objective, the data obtained may have additional 
value since they provide a  quantitative comparison of the different host reactions to 
a  single endotoxin. Data  from  the  individual protocols (Tables VI to X)  were re- 
calculated to obtain an expression of the reduced potencies as related to the original 
endotoxin, i.e., relative potencies, and these are given in Table XI. It is apparent that 
as little as 5 minutes of hydrolysis was sufficient to reduce endotoxin potency 50 per 
cent or more in four out of five of the activities measured. Thereafter, at 15, 30, and 
45  minutes, endotoxic activity, as measured in each of the five different tests, con- 
tinued  to  deteriorate.  There  appeared  to  be  some  indication that  the  capacity to 
TABLE XI 
Changes in Biological Activities of Endotoxin During Hydrolysis with 0.1 N  Acetic Acid 
I  / 
Free lipid*  Resistance to  Tumor  Mouse  [  Dermal  ]  Pyrogenicity 
Duration  of  infection  damage  lethality  [ inflammation 
treatment 
with acid 
Relative potency 
mm. 
0 
5 
15 
30 
45 
60 
90 
180 
360 
per ce~g 
0.0 
0.0 
0.2 
0.6 
2.0 
1.0 
1.41 
0.83 
0.27 
0.066 
0.062 
<0.009 
<0.002 
<0.006 
1.0 
0.5 
0.12 
0.025 
0.0055 
0.0025 
<0.003 
<0.003 
<0.003 
1.0 
0.49 
0.21 
0.14 
0.054 
<0.05 
<0.03 
<0.03 
<0.02 
1.0 
0.41 
0.41 
0.18 
0.061 
O. 033 
O. 038 
0.015 
0.0077 
1.0 
0.27 
0.39 
0.18 
0.14 
0.093 
0.013 
0.0033 
0.0007 
* Chloroform-soluble  material extracted from  hydrolysates. 
induce  tumor  damage  declined  more  rapidly  than  the  other  properties,  whereas 
pyrogenic capability was somewhat more resistant to destruction, but in general as 
hydrolysis proceeded the diverse properties declined at rates which were remarkably 
similar. It is especially noteworthy that up to 60 minutes, when the loss of biologic 
potency had become pronounced, very little lipid had been released and the turbidity 
of the reaction mixture did not differ from that of the zero time sample (Table XI). 
After 90 minutes, a  slight increase in turbidity of the hydrolysate was observed, and 
a  measurable quantity  (0.6  per  cent)  of bound  lipid which  had  been  set free  was 
recovered.  At this  stage,  the  decline in  pyrogenic potency was  77-fold which  was 
about that  expected from results of studies with  the  artificial lipoprotein in which 
the endotoxin complex had been exposed to the same conditions of hydrolysis. Other 
activities  measured  had  declined  similarly.  With  continuing  hydrolysis,  further 
deterioration occurred, but available quantities of material precluded attainment of 
end points in all but the most sensitive tests. At the time the experiment was ter- 
minated (6 hours), chloroform-extractable material totaling 2.0 per cent of the endo- 680  ENDOTOXINS  AND  LIPOID  FRACTIONS 
toxin had  been released.  Since hydrolysis  of this  endotoxin with  1 N hydrochloric 
acid  for 45  minutes yielded 6.4 per cent chloroform-soluhle  lipid  A, no more than 
one-tenth  of  this  fraction  could  have been released  by 90  minutes of hydrolysis 
with acetic acid. 
Chemical analyses  carried out on samples of the endotoxin at the various stages 
of hydrolysis (non-dialyzable  residues) revealed that the content of nitrogen, hexose, 
total  carbohydrate, and  rhamnose  did  not undergo  significant  change  during  hy- 
drolysis. 
DISCUSSION 
In this study we have utilized a number of dose-related assays in parallel tests 
to determine the relative potencies of endotoxins and lipoid fractions derived 
from them. The results of these bio-assays consistently demonstrated that endo- 
toxins were, to an unexpected degree, far more potent than their corresponding 
lipids.  When  the  lipid  was  separated  following  protracted  acid  hydrolysis, 
smaller polysaccharide units remained which were devoid of endotoxic proper- 
ties. Employment of non-hydrolytic methods for separation of lipid left a resid- 
ual material of full endotoxic potency. It was not surprising, therefore, that the 
lipids separated in this manner did not contain a  significant part of the initial 
potency.  Extension of  such  methods  eventually  resulted  in  preparations  of 
active endotoxin with total fatty acid content no greater than that found in the 
haptenic polysaccharides produced by acid hydrolysis (6). 
Examination of the various lipoid fractions themselves did indeed show that, 
whether obtained by hydrolytic or by non-hydrolytic methods, some of them 
displayed activity, but of a low order. The fact that the potencies were of similar 
magnitude may have a bearing on whether or not the low potency of lipid A is 
to be attributed to the damage inflicted by acid hydrolysis. Nowotny has found 
the "firmly bound" lipid (purified lipid A) to be a mixture of at least 16 different 
components (personal communication) and has reported the structure of 1 of 
these components, a phosphomucolipid (15). This new lipid, containing a poly- 
D-glucosamine phosphate  chain in which glucosamine is  esterified with fatty 
acids, was reported by Westphal (16) to be responsible for many of the phar- 
macological effects characteristic of endotoxins. We have not tested any of the 
pure component but, as reported here, there was no correlation between hexos- 
amine content and biological activity in any of the lipid fractions tested. 
In general, our experiments provided no support for the concept that the lipid 
moiety is solely, or even chiefly, responsible for the biologic activity of endo- 
toxin. When the biologic data,  expressed in terms of the weight of lipid em- 
ployed, are calculated in terms of lipid content in the starting material,  the 
disparity is even greater than appears at first sight. If lipid were solely respon- 
sible for the endotoxic activity of lipopolysaccharides, and if it constituted 10 
per cent of the complex, then it should have, on an absolute weight basis,  10 HASKINS,  LANDY,  MILNER, AND  RIBI  681 
times the activity d  the whole endotoxin, provided it were suitably dispersed 
and not altered in the process of isolation.  By the same reasoning,  the lipid from 
an active preparation containing only 2 per cent of this constituent should have 
a correspondingly greater relative potency. We have, in fact, not yet obtained a 
lipid fraction from 1 of our endotoxins, which, on an absolute weight basis,  ex- 
hibited more than 1/~00 of the activity of the parent endotoxin. The implication 
of our findings, then, is that the contribution of this moiety to the characteristic 
activities of endot0xir~ is of a minor nature and, because of its resistance to acid, 
entirely separate from the principal activity. 
In the study of the rate at which the biologic activity of endotoxin diminished 
during the early stages of acid hydrolysis, the bio-assays were paralleled by de- 
termination  of released lipid.  Progressive loss of biologic potency became evi- 
dent in the course of the hydrolysis before any measurable chloroform-soluble 
lipid  was released.  Obviously, separation and decreased solubility of the lipid 
moiety were not responsible for loss of potency. The intermediate activity of 
artificial  lipoproteins could, however, be accounted for by the fact that their ac- 
tivity was just about what might be expected from the conditions of hydrolysis 
to which the original endotoxin used in their preparation had been subjected. 
This kinetic study was carded out with endotoxin prepared from S. enteritidis, 
and the conclusions  drawn are restricted to this preparation. Analogous exam- 
inations of endotoxin, prepared by various methods from various bacterial spe- 
cies,  will,  of course,  be required  before any generalization  on this  subject is 
made. Since Boivin and Mesrobeanu showed in 1935 (19) that dilute acetic acid 
was capable of splitting endotoxin with attendant loss of biological activity, ex- 
cept for the in vitro specificity manifested by the degraded haptenic polysac- 
charide,  there has been ample confirmation  (18, 20-22). Tal and Goebel (23) 
reported that, when a purified  toxic material (TM) from ShigeUa paradysenter- 
iae was heated for 1 hour with 1 per cent acetic acid, toxicity was destroyed but 
the solution remained clear and chloroform-extractable material was not lib- 
erated. They also showed the progressive destruction of lethality for mice by 
brief acid hydrolysis of a crude antigen from the same organism.  Superficially, 
at least, these findings are in agreement with ours. 
Previously, removal of protein and reduction of nitrogen content to 0.6 per 
cent without loss of endotoxic potency was accomplished (18). Now that it is 
found that lipid also can be reduced to the same low level found in the haptenlc 
polysaccharide, the features of structure required for the biologic effects remain 
to be elucidated.  With these newer preparations,  high  potency is present, in 
sharp contrast to the absence of activity in the haptene, although chemical data 
thus far have revealed no important difference, at least with regard to nitrogen, 
phosphorus, hexosamine,  carbohydrate, and fatty acid. 
An important  function for the small  amount of lipid and nitrogenous sub- 
stance in the most highly refined endotoxin cannot be excluded by the present 682  ENDOTOXINS AND LIPOID FRACTIONS 
evidence, although it is conceivable that these may yet be removed completely 
by suitable non-hydrolytic methods without damage to the residual endotoxin. 
If major toxic properties are to be attributed to either of these materials, it may 
be supposed that they are sensitive to acid and that means are not available for 
isolating them in an active form. They could also be important if the unique ef- 
fects of endotoxins on the mammalian host are a reflection of macromolecular 
organization: either or both could be active only if attached to a complex of a 
critical size, or could contribute to activity by furnishing bonds to give cohesion 
or form to a large molecule. Questions such as these, and the role of the macro- 
molecular properties of the polymeric sugar components themselves are now 
being approached experimentally. 
SUMMARY 
The biological potencies of a number of lipid fractions separated from endo- 
toxins by acid hydrolysis, including the materiM known as lipid A, were deter- 
mined in parallel with those of their parent endotoxins, employing bio-assays 
based on the following dose-related host responses: fever, resistance to infection, 
tumor damage, primary inflammation of skin, and lethality. Without exception, 
lipid fractions dispersed by detergents exerted less than  1 per cent of the bio- 
logical activity of the potent endotoxins from which they were derived. 
A study was made of the rate at which biologic activities diminished in rela- 
tion to the release of bound lipid during progressive hydrolysis of Salmonella 
enteritidis endotoxin with dilute acid. Each of the five assays for endotoxin re- 
vealed that biological activity had been reduced to negligible proportions prior 
to any significant liberation from the endotoxin of water-insoluble firmly bound 
lipid. The major pharmacological activity of endotoxins, therefore, is acid-labile 
and cannot be accounted for in isolated lipids. This conclusion is also supported 
by the finding that lipids with activity similar to that of lipid A could be ob- 
tained  by  non-hydrolytic methods  without  diminishing  the  potency of  the 
parent endotoxins. 
We wish to acknowledge  the encouragement,  counsel, and assistance in the preparation of 
these reports given by our National Institutes of Health colleagues  with extensive experience 
in this field, Drs. Murray J. Shear and Marion Webster. We are indebted to Dr. R.-J. Trapani 
for invaluable assistance in performance  of tumor damage and pyrogen assays for endotoxin. 
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